At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 64 enrolled
Drug / intervention
0.9% Sodium Chloride +1 moredrug
Likely dose
0.9% Sodium Chloride 100 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of Nebulized 3% Hypertonic Saline With Salbutamol in the Treatment of Acute Bronchiolitis in Pediatric Hospital
Coordinación de Investigación en Salud, Mexico·interventional·Posted Sep 9, 2014·Updated Jun 21, 2017
In Brief
A Phase 4 clinical trial evaluating 0.9% Sodium Chloride and 3% Sodium Chloride for Bronchiolitis and Wheezing. Completed, enrolled 64 participants across 1 site.
Detailed Summary
\- Determine the efficacy of nebulized salbutamol/hypertonic saline combination in moderate to severe bronchiolitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis, Wheezing
CountriesMexico
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedSep 2014
Primary CompletionFeb 2017
Study CompletionMar 2017
TodayJul 2026
First PostedSep 9, 2014
Enrollment StartAug 1, 2013
Primary CompletionFeb 1, 2017
Study CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 11.8 years ago
Interventions
0.9% Sodium Chloridedrug
Salbutamol 100 micrograms / kg / dose administered 0.9% saline solution (4ml) nebulized for 3 initial sessions lasting 20 minutes each and every 4 hours during the entire hospital stay.
3% Sodium Chloridedrug
Salbutamol 100 micrograms / kg / dose administered 3 % saline solution (4ml) nebulized for 3 initial sessions lasting 20 minutes each and every 4 hours during the entire hospital stay.